Skip navigation Jump to main navigation

Robert Klitzman on EpiPen's Price Hike

With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.

Read the full article at CNN.

Related News

All News
Gregory Wawro, professor of political science and program director of the M.S. in Political Analytics

Anatomy of the 2026 Blunami

All News